Osaka, Japan

Kayoko Maeda


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1993-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kayoko Maeda: Innovator in Thiazine Derivatives

Introduction

Kayoko Maeda is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of thiazine derivatives. With a total of 3 patents to her name, her work focuses on compounds that exhibit calcium antagonistic activity, which are crucial for treating ischemic encephalopathia.

Latest Patents

Maeda's latest patents include innovative formulations of thiazine derivatives. One of her notable inventions is a thiazine derivative that has been designed to have calcium antagonistic activity within cerebral tissues. This compound is useful for the prophylaxis and treatment of ischemic encephalopathia. Another patent involves thiazine derivatives that can form a naphthalene ring with a benzene ring, showcasing her expertise in creating complex chemical structures that have therapeutic potential.

Career Highlights

Kayoko Maeda is currently employed at Tanabe Seiyaku Company, Limited, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of thiazine derivatives and their applications in medicine.

Collaborations

Throughout her career, Maeda has collaborated with esteemed colleagues such as Masakatsu Ozeki and Shin-ichi Kodato. These collaborations have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Kayoko Maeda stands out as a leading inventor in the field of medicinal chemistry, with her groundbreaking work on thiazine derivatives paving the way for new treatments in neurology. Her contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…